Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2019

01-04-2019 | Original Article

Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study

Authors: Sohier Yahia, Yahya Wahba, Abdel-Hady El-Gilany, Suzy Abdelmabood, Mohamed Adel El-Hadidy, Ahmad Darwish, Ahmed K. Mansour

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2019

Login to get access

Abstract

The impact of chronic immune thrombocytopenic purpura (ITP) on the psychological health and quality of life is evident among children and adolescents. We aimed to describe psychological disorders and assess quality of life in children with chronic ITP and compared their results with their healthy peers. A cross-sectional comparative study was carried out in a tertiary care university-affiliated hospital during a period from November, 2015 till April, 2018. We enrolled 119 children with chronic ITP and compared with 220 healthy peers. Relevant demographic and clinical data were collected and statistically analyzed. Quality of life for both patients and control groups was measured using pediatric quality of life inventory version 4 (Arabic one). Also psychiatric evaluation of both groups was done using Arabic version of Mini-International Neuropsychiatric Interview for Children (Mini-KID). Majority of patients (90.7%) exhibited mucocutaneous bleeding. Most of patients (61.3%) did not need any definitive treatment for chronic ITP while 38.6% received second line therapy. About one-third of the patients needed rescue medications to control active bleeding. The scores of all sub-scales of Peds QL 4.0 were significantly decreased among patients group when compared to their healthy peers (P < 0.001). General anxiety disorder and oppositional defiant disorders were the commonest psychiatric disorders among children with chronic ITP. Quality of life in children with chronic ITP is markedly impaired with occurrence of a variable spectrum of psychiatric disorders among the studied patients.
Literature
3.
go back to reference Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 6:16CrossRefPubMedCentral Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 6:16CrossRefPubMedCentral
4.
5.
go back to reference George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4:1664–1672CrossRefPubMed George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4:1664–1672CrossRefPubMed
6.
go back to reference Yong M, Schoonen WM, Li L et al (2010) Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 149:855–864CrossRefPubMed Yong M, Schoonen WM, Li L et al (2010) Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol 149:855–864CrossRefPubMed
7.
go back to reference Terrell DR, Beebe LA, Vesely SK et al (2010) The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 85:174–180CrossRefPubMed Terrell DR, Beebe LA, Vesely SK et al (2010) The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 85:174–180CrossRefPubMed
8.
go back to reference Neunert CE, Buchanan GR, Blanchette V et al (2009) Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53:652–654CrossRefPubMed Neunert CE, Buchanan GR, Blanchette V et al (2009) Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53:652–654CrossRefPubMed
9.
go back to reference Alesci SR, Schwan V, Miesbach W et al (2013) Rare bleeding disorders are associated with depression and anxiety. Hamostaseologie 33:S64–S68PubMed Alesci SR, Schwan V, Miesbach W et al (2013) Rare bleeding disorders are associated with depression and anxiety. Hamostaseologie 33:S64–S68PubMed
11.
go back to reference Group W, others (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef Group W, others (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef
12.
go back to reference Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol 36:194–199CrossRefPubMed Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol 36:194–199CrossRefPubMed
13.
go back to reference Heitink-Pollé KMJ, Haverman L, Annink KV et al (2014) Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica 99:1525–1531CrossRefPubMedCentralPubMed Heitink-Pollé KMJ, Haverman L, Annink KV et al (2014) Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica 99:1525–1531CrossRefPubMedCentralPubMed
14.
go back to reference Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393CrossRef Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393CrossRef
15.
go back to reference Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRef Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRef
16.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH et al (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232–241CrossRef Sheehan DV, Lecrubier Y, Sheehan KH et al (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232–241CrossRef
17.
go back to reference Ibrahim M, Bishry Z, Hamed A (2002) Comparison of mini international neuropsychiatric interview for children (MINI-KID) with the schedules for affective disorders and schizophrenia for school aged children, present and lifetime version (KSADS-PL). In: Egyptian sample presenting with childhoo. MD thesis, Ain Shams University Ibrahim M, Bishry Z, Hamed A (2002) Comparison of mini international neuropsychiatric interview for children (MINI-KID) with the schedules for affective disorders and schizophrenia for school aged children, present and lifetime version (KSADS-PL). In: Egyptian sample presenting with childhoo. MD thesis, Ain Shams University
18.
go back to reference Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207CrossRefPubMed Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190–4207CrossRefPubMed
19.
go back to reference Alam MM (2014) Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc 64:1358–1362PubMed Alam MM (2014) Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc 64:1358–1362PubMed
20.
go back to reference Nazari SH, Abdollah Gorji F, Sadeghi-Koupai MT (2012) Epidemiology of idiopathic thrombocytopenic purpura in children. Iran J Pediatr Hematol Oncol 2:35–39 Nazari SH, Abdollah Gorji F, Sadeghi-Koupai MT (2012) Epidemiology of idiopathic thrombocytopenic purpura in children. Iran J Pediatr Hematol Oncol 2:35–39
21.
go back to reference Journeycake JM (2012) Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. ASH Educ Progr B 2012:444–449 Journeycake JM (2012) Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. ASH Educ Progr B 2012:444–449
22.
go back to reference Neunert CE, Buchanan GR, Imbach P et al (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112:4003–4008CrossRefPubMedCentralPubMed Neunert CE, Buchanan GR, Imbach P et al (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112:4003–4008CrossRefPubMedCentralPubMed
23.
go back to reference Zhang H, Wang L, Quan M et al (2016) Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes 14:45CrossRefPubMedCentralPubMed Zhang H, Wang L, Quan M et al (2016) Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes 14:45CrossRefPubMedCentralPubMed
24.
go back to reference Mathias SD, Gao SK, Miller KL et al (2008) Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6:13CrossRefPubMedCentralPubMed Mathias SD, Gao SK, Miller KL et al (2008) Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6:13CrossRefPubMedCentralPubMed
25.
26.
go back to reference McMillan R, Bussel JB, George JN et al (2008) Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 83:150–154CrossRefPubMed McMillan R, Bussel JB, George JN et al (2008) Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 83:150–154CrossRefPubMed
28.
go back to reference Rosthøj S, Rajantie J, Treutiger I et al (2012) Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a nordic cohort. Acta Paediatr 101:761–766CrossRefPubMed Rosthøj S, Rajantie J, Treutiger I et al (2012) Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a nordic cohort. Acta Paediatr 101:761–766CrossRefPubMed
Metadata
Title
Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study
Authors
Sohier Yahia
Yahya Wahba
Abdel-Hady El-Gilany
Suzy Abdelmabood
Mohamed Adel El-Hadidy
Ahmad Darwish
Ahmed K. Mansour
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1031-0

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine